Literature DB >> 14661684

Obstructive sleep apnea-hypopnea syndrome.

Eric J Olson1, Wendy R Moore, Timothy I Morgenthaler, Peter C Gay, Bruce A Staats.   

Abstract

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is characterized by repetitive episodes of airflow reduction (hypopnea) or cessation (apnea) due to upper airway collapse during sleep. Increasing recognition and a greater understanding of the scope of this condition have substantially affected the practices of many clinicians. This review provides practical information for physicians assessing patients with OSAHS. It discusses complications, clinical recognition, the polysomnographic report, and treatment of OSAHS, including strategies for troubleshooting problems associated with continuous positive airway pressure therapy.

Entities:  

Mesh:

Year:  2003        PMID: 14661684     DOI: 10.4065/78.12.1545

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  16 in total

1.  Obstructive sleep apnea and depression: a review.

Authors:  Shakir M Ejaz; Imran S Khawaja; Subhash Bhatia; Thomas D Hurwitz
Journal:  Innov Clin Neurosci       Date:  2011-08

Review 2.  Updates on definition, consequences, and management of obstructive sleep apnea.

Authors:  John G Park; Kannan Ramar; Eric J Olson
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

3.  High flow nasal cannula therapy for obstructive sleep apnea in adults.

Authors:  Hu Yan; Li Qinghua; Pi Mengyuan; Chen Yaoyu; Zhao Long; Li Mengjie; Dong Xiaosong; Han Fang
Journal:  Sleep Breath       Date:  2021-08-12       Impact factor: 2.816

4.  Comparison of the value of the STOP-BANG questionnaire with oxygen desaturation index in screening obstructive sleep apnea in Germany.

Authors:  Yan Wang; Ingo Fietze; Matthew Salanitro; Thomas Penzel
Journal:  Sleep Breath       Date:  2022-10-21       Impact factor: 2.655

5.  A nasal cannula can be used to treat obstructive sleep apnea.

Authors:  Brian M McGinley; Susheel P Patil; Jason P Kirkness; Philip L Smith; Alan R Schwartz; Hartmut Schneider
Journal:  Am J Respir Crit Care Med       Date:  2007-03-15       Impact factor: 21.405

6.  Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.

Authors:  Max Hirshkowitz; Jed Black
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Coexistence of Obstructive Sleep Apnea and Superior Vena Cava Syndromes Due to Substernal Goitre in a Patient With Respiratory Failure: A Case Report.

Authors:  Mehtap Tunc; Hilal Sazak; Bulent Karlilar; Fatma Ulus; Irfan Tastepe
Journal:  Iran Red Crescent Med J       Date:  2015-05-31       Impact factor: 0.611

8.  Obstructive sleep apnea hypopnea syndrome.

Authors:  Gc Mbata; Jc Chukwuka
Journal:  Ann Med Health Sci Res       Date:  2012-01

9.  Diagnosis and treatment of sleep apnea in heart disease.

Authors:  Julio A Barcena; James C Fang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

10.  Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.

Authors:  Thomas Roth; Gregory A Rippon; Sanjay Arora
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.